BMS-159
BMS-159 is an orally active, direct phosphate prodrug of BMS-135. BMS-135 is a potent ATP-competitive inhibitor of CK2. BMS-159 can be used in the research of neurological disorders and tumors.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1541248-45-6
- Formule: C22H24ClN10O6P
- Masse moléculaire:590.92
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
CK2 |
Chemical Information
-
CAS No. 1541248-45-6
-
Masse moléculaire 590.92
-
Formule C22H24ClN10O6P
-
SMILES
N#CC1=CN=C2N1N=C(N=C2NCC)NC3=C(C(N4C[C@H]([C@@H](CC4)NC(OC)=O)OP(O)(O)=O)=CC(C#N)=C3)Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. A M Subbaiah M, et al. Enhancing the Oral Bioavailability of a Poorly Soluble Pan-CK2 Kinase Inhibitor: Leveraging a Phosphate Prodrug Strategy to Overcome Dissolution-Limited Absorption and Improve Systemic Exposure during Dose Escalation. J Med Chem. 2026 Jan 22;69(2):1641-1660. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)